{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T17:09:47Z","timestamp":1779988187994,"version":"3.53.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,22]]},"DOI":"10.7759\/cureus.43898","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T08:41:13Z","timestamp":1692693673000},"source":"Crossref","is-referenced-by-count":3,"title":["Microbiological Spectrum of Neutropenic Sepsis in Cancer Patients Admitted to a Tertiary Health Care Centre"],"prefix":"10.7759","author":[{"given":"Kevin R","family":"John","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Warrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Warrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-845-4_1","article-title":"The role of neutrophils in the immune system: an overview","volume":"1124","author":"Malech HL","year":"2014","unstructured":"Malech HL, Deleo FR, Quinn MT. The role of neutrophils in the immune system: an overview. Methods Mol Biol. 2014, 1124:3-10. 10.1007\/978-1-62703-845-4_1","journal-title":"Methods Mol Biol"},{"key":"ref2","article-title":"Management of neutropenia in cancer patients","volume":"10","author":"Lustberg MB","year":"2012","unstructured":"Lustberg MB. Management of neutropenia in cancer patients. Clin Adv Hematol Oncol. 2012, 10:825-6.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.4103\/0019-509X.63019","article-title":"Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern","volume":"47","author":"Prabhash K","year":"2010","unstructured":"Prabhash K, Medhekar A, Ghadyalpatil N, et al.. Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern. Indian J Cancer. 2010, 47:184.","journal-title":"Indian J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200208000-00004","article-title":"Treatment of febrile neutropenia: what is new?","volume":"15","author":"Viscoli C","year":"2002","unstructured":"Viscoli C, Castagnola E. Treatment of febrile neutropenia: what is new?. Curr Opin Infect Dis. 2002, 15:377-82. 10.1097\/00001432-200208000-00004","journal-title":"Curr Opin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States","volume":"36","author":"Wisplinghoff H","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clinical Infectious Diseases. 2003, 36:1103-10.","journal-title":"Clinical Infectious Diseases"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1078155213492450","article-title":"Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings","volume":"20","author":"Weycker D","year":"2014","unstructured":"Weycker D, Barron R, Kartashov A, Legg J, Lyman GH. Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings. J Oncol Pharm Pract. 2014, 20:190-8. 10.1177\/1078155213492450","journal-title":"J Oncol Pharm Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181b1edc6","article-title":"Etiology and clinical course of febrile neutropenia in children with cancer","volume":"31","author":"Hakim H","year":"2009","unstructured":"Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH. Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2009, 31:623-9. 10.1097\/MPH.0b013e3181b1edc6","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref8","article-title":"Febrile neutropenia comparison between solid tumours and hematological malignancies","volume":"2","author":"Al-Ahwal MS","year":"2005","unstructured":"Al-Ahwal MS, Al-Sayws F, Johar I. Febrile neutropenia comparison between solid tumours and hematological malignancies. PAN Arab Medical Journal. 2005, 2:4-7.","journal-title":"PAN Arab Medical Journal"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2015.524","article-title":"Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study","volume":"3","author":"DE Castro Carpe\u00f1o J","year":"2015","unstructured":"DE Castro Carpe\u00f1o J, Gasc\u00f3n-Vilaplana P, Tejerina AM, et al.. Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study. Mol Clin Oncol. 2015, 3:725-9. 10.3892\/mco.2015.524","journal-title":"Mol Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.11.005","article-title":"Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: an overview about well-established and recently emerging clinical data","volume":"120","author":"Lalami Y","year":"2017","unstructured":"Lalami Y, Klastersky J. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: an overview about well-established and recently emerging clinical data. Crit Rev Oncol Hematol. 2017, 120:163-79. 10.1016\/j.critrevonc.2017.11.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/11592980-000000000-00000","article-title":"Costs associated with febrile neutropenia in the US","volume":"30","author":"Michels SL","year":"2012","unstructured":"Michels SL, Barron RL, Reynolds MW, Smoyer Tomic K, Yu J, Lyman GH. Costs associated with febrile neutropenia in the US. Pharmacoeconomics. 2012, 30:809-23. 10.2165\/11592980-000000000-00000","journal-title":"Pharmacoeconomics"},{"key":"ref12","article-title":"Management of febrile neutropenia: ESMO Clinical Practice Guidelines","volume":"5","author":"de Naurois J","year":"2010","unstructured":"de Naurois J, Novitzky-Basso I, Gill MJ, et al.. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2010, 5:252-6.","journal-title":"Ann Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld AG","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, et al.. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011, 52:e56-93. 10.1093\/cid\/cir073","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/986938","article-title":"Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update","volume":"2014","author":"Villafuerte-Gutierrez P","year":"2014","unstructured":"Villafuerte-Gutierrez P, Villalon L, Losa JE, Henriquez-Camacho C. Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update. Adv Hematol. 2014, 2014:986938. 10.1155\/2014\/986938","journal-title":"Adv Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2727.78555","article-title":"Pancytopenia: a clinico hematological study","volume":"3","author":"Gayathri BN","year":"2011","unstructured":"Gayathri BN, Rao KS. Pancytopenia: a clinico hematological study. J Lab Physicians. 2011, 3:15-20. 10.4103\/0974-2727.78555","journal-title":"J Lab Physicians"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos AP","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al.. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012, 18:268-81. 10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"ref17","article-title":"The International Classification of Diseases, 9th Revision, Clinical Modification: Procedures: tabular list and alphabetic index (Vol. 3)","author":"US Department of Health and Human Services","year":"1980","unstructured":"US Department of Health and Human Services. The International Classification of Diseases, 9th Revision, Clinical Modification: Procedures: tabular list and alphabetic index (Vol. 3). World Health Organization, & National Center for Health Statistics, USA; 1980."},{"key":"ref18","unstructured":"CLSI Standards &  Guidelines. Accessed. August 2023: https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1086\/383042","article-title":"Microbiological data for patients with febrile neutropenia","volume":"39 Suppl 1","author":"Kanamaru A","year":"2004","unstructured":"Kanamaru A, Tatsumi Y. Microbiological data for patients with febrile neutropenia. Clin Infect Dis. 2004, 39 Suppl 1:S7-S10. 10.1086\/383042","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.175330","article-title":"Clinical and microbiological profile of febrile neutropenia in solid tumors and hematological malignancies at a tertiary cancer care center in South India","volume":"51","author":"Jacob LA","year":"2014","unstructured":"Jacob LA, Lakshmaiah KC, Govindbabu K, et al.. Clinical and microbiological profile of febrile neutropenia in solid tumors and hematological malignancies at a tertiary cancer care center in South India. Indian J Cancer. 2014, 51:464-8. 10.4103\/0019-509X.175330","journal-title":"Indian J Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0188-4409(00)00080-1","article-title":"Microbiological findings in febrile neutropenia","volume":"31","author":"Gayt\u00e1n-Mart\u00ednez J","year":"2000","unstructured":"Gayt\u00e1n-Mart\u00ednez J, Mateos-Garc\u00eda E, S\u00e1nchez-Cort\u00e9s E, Gonz\u00e1lez-Llaven J, Casanova-Cardiel LJ, Fuentes-Allen JL. Microbiological findings in febrile neutropenia. Arch Med Res. 2000, 31:388-92. 10.1016\/s0188-4409(00)00080-1","journal-title":"Arch Med Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1086\/427329","article-title":"Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification","volume":"40 Suppl 4","author":"Viscoli C","year":"2005","unstructured":"Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis. 2005, 40 Suppl 4:S240-5. 10.1086\/427329","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-010-0029-z","article-title":"Microbial etiology of febrile neutropenia","volume":"26","author":"Swati M","year":"2010","unstructured":"Swati M, Gita N, Sujata B, Farah J, Preeti M. Microbial etiology of febrile neutropenia. Indian J Hematol Blood Transfus. 2010, 26:49-55. 10.1007\/s12288-010-0029-z","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref24","article-title":"Infections in acute myeloid leukemia. Study of 184 febrile episodes","volume":"40","author":"Kumar L","year":"1992","unstructured":"Kumar L, Kochupillai V, Bhujwala RA. Infections in acute myeloid leukemia. Study of 184 febrile episodes. J Assoc Physicians India. 1992, 40:18-20.","journal-title":"J Assoc Physicians India"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1086\/646869","article-title":"Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies","volume":"15","author":"Rubio M","year":"1994","unstructured":"Rubio M, Palau L, Vivas JR, et al.. Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol. 1994, 15:101-4. 10.1086\/646869","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.106103","article-title":"Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome","volume":"170","author":"Pulingam T","year":"2022","unstructured":"Pulingam T, Parumasivam T, Gazzali AM, et al.. Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci. 2022, 170:106103. 10.1016\/j.ejps.2021.106103","journal-title":"Eur J Pharm Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5419874","article-title":"Multidrug-resistant bacteria: their mechanism of action and prophylaxis","volume":"2022","author":"Bharadwaj A","year":"2022","unstructured":"Bharadwaj A, Rastogi A, Pandey S, Gupta S, Sohal JS. Multidrug-resistant bacteria: their mechanism of action and prophylaxis. Biomed Res Int. 2022, 2022:5419874. 10.1155\/2022\/5419874","journal-title":"Biomed Res Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/172086-microbiological-spectrum-of-neutropenic-sepsis-in-cancer-patients-admitted-to-a-tertiary-health-care-centre","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:23Z","timestamp":1707508343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/172086-microbiological-spectrum-of-neutropenic-sepsis-in-cancer-patients-admitted-to-a-tertiary-health-care-centre"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.43898","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,22]]}}}